Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monitoring individualized glucose levels predicts risk for bradycardia in type 2 diabetes patients with chronic kidney disease: a pilot study.
Farhadi Ghalati P, E Samadi M, Verket M, Balfanz P, Müller-Wieland D, Jonas S, Napp A, Wanner C, Ketteler M, Vassiliadou A, Heidenreich S, Deserno T, Hetzel G, Fliser D, Kelm M, Floege J, Marx N, Schuppert A. Farhadi Ghalati P, et al. Among authors: muller wieland d. Sci Rep. 2024 Dec 5;14(1):30290. doi: 10.1038/s41598-024-81983-x. Sci Rep. 2024. PMID: 39638855 Free PMC article.
Effectiveness and safety of insulin glargine 300 U/mL in insulin-naïve individuals according to diabetes duration: Results from the REALI European pooled data analysis.
Gourdy P, Bonadonna RC, Mauricio D, Müller-Wieland D, Mauquoi C, Vera C, Bonnemaire M, Freemantle N. Gourdy P, et al. Among authors: muller wieland d. Diabetes Obes Metab. 2025 Jan;27(1):228-237. doi: 10.1111/dom.16008. Epub 2024 Oct 17. Diabetes Obes Metab. 2025. PMID: 39420531 Free PMC article.
Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction.
Marx N, Rydén L, Federici M, Marx-Schütt K, Verket M, Müller-Wieland D, Gerstein HC, Chan J, Cosentino F, Holman RR, Mellbin L, Ray KK, Standl E, Verma S, Wood D, Tuomilehto J, De Caterina R. Marx N, et al. Among authors: muller wieland d. Eur Heart J. 2024 Dec 23;45(48):5117-5126. doi: 10.1093/eurheartj/ehae533. Eur Heart J. 2024. PMID: 39387537 Review.
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease.
Zhang H, Targher G, Byrne CD, Kim SU, Wong VW, Valenti L, Glickman M, Ponce J, Mantzoros CS, Crespo J, Gronbaek H, Yang W, Eslam M, Wong RJ, Machado MV, Yu ML, Ghanem OM, Okanoue T, Liu JF, Lee YH, Xu XY, Pan Q, Sui M, Lonardo A, Yilmaz Y, Zhu LY, Moreno C, Miele L, Lupsor-Platon M, Zhao L, LaMasters TL, Gish RG, Zhang H, Nedelcu M, Chan WK, Xia MF, Bril F, Shi JP, Datz C, Romeo S, Sun J, Liu D, Sookoian S, Mao YM, Méndez-Sánchez N, Wang XY, Pyrsopoulos NT, Fan JG, Fouad Y, Sun DQ, Giannini C, Chai J, Xia ZF, Jun DW, Li GJ, Treeprasertsuk S, Li YX, Cheung TT, Zhang F, Goh GB, Furuhashi M, Seto WK, Huang H, Di Sessa A, Li QH, Cholongitas E, Zhang L, Silveira TR, Sebastiani G, Adams LA, Chen W, Qi X, Rankovic I, De Ledinghen V, Lv WJ, Hamaguchi M, Kassir R, Müller-Wieland D, Romero-Gomez M, Xu Y, Xu YC, Chen SY, Kermansaravi M, Kuchay MS, Lefere S, Parmar C, Lip GYH, Liu CJ, Åberg F, Lau G, George J, Sarin SK, Zhou JY, Zheng MH; MAFLD ICD-11 coding collaborators. Zhang H, et al. Among authors: muller wieland d. Hepatol Int. 2024 Aug;18(4):1178-1201. doi: 10.1007/s12072-024-10702-5. Epub 2024 Jun 15. Hepatol Int. 2024. PMID: 38878111
Impact of telemedical management on hospitalization and mortality in heart failure patients with diabetes: a post-hoc subgroup analysis of the TIM-HF2 trial.
Koehler F, Koehler J, Bramlage P, Vettorazzi E, Wegscheider K, Lezius S, Spethmann S, Iakoubov R, Vijayan A, Winkler S, Melzer C, Schütt K, Dessapt-Baradez C, Paar WD, Koehler K, Müller-Wieland D. Koehler F, et al. Among authors: muller wieland d. Cardiovasc Diabetol. 2024 Jun 12;23(1):198. doi: 10.1186/s12933-024-02285-0. Cardiovasc Diabetol. 2024. PMID: 38867198 Free PMC article. Clinical Trial.
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Manvelian G, Pordy R, Poulouin Y, Stipek W, Garon G, Schwartz GG; ODYSSEY OUTCOMES Investigators. Goodman SG, et al. Eur Heart J Cardiovasc Pharmacother. 2024 Jul 16;10(4):342-352. doi: 10.1093/ehjcvp/pvae025. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38658193 Free PMC article. Review.
Therapy of Type 2 Diabetes.
Landgraf R, Aberle J, Birkenfeld AL, Gallwitz B, Kellerer M, Klein HH, Müller-Wieland D, Nauck MA, Wiesner T, Siegel E. Landgraf R, et al. Among authors: muller wieland d. Exp Clin Endocrinol Diabetes. 2024 Jul;132(7):340-388. doi: 10.1055/a-2166-6755. Epub 2024 Apr 10. Exp Clin Endocrinol Diabetes. 2024. PMID: 38599610 Free article. No abstract available.
Correction: Definition, Classification, Diagnosis and Differential Diagnosis of Diabetes Mellitus: Update 2023.
Pleus S, Tytko A, Landgraf R, Heinemann L, Werner C, Müller-Wieland D, Ziegler AG, Müller UA, Freckmann G, Kleinwechter H, Schleicher E, Nauck M, Petersmann A. Pleus S, et al. Among authors: muller wieland d. Exp Clin Endocrinol Diabetes. 2024 Mar;132(3):e1. doi: 10.1055/a-2277-1648. Epub 2024 Mar 14. Exp Clin Endocrinol Diabetes. 2024. PMID: 38484786 Free article. No abstract available.
234 results